Temple Faculty Physicians is experiencing technical issues with phone lines. If you are experiencing an emergency, please visit your nearest emergency room. If you would like to schedule an appointment with your provider or have general questions or requests, please contact us by using myTempleHealth.

myTempleHealth
800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis (KITE)

view all Clinical Trials

Overview

This is a Phase 2, randomized, double-blind, placebo-controlled, adaptive, multicenter study to evaluate the efficacy, safety, tolerability, Pharmacodynamics (PD), and Pharmacokinetics (PK) of OATD-01 in the treatment of subjects with active pulmonary sarcoidosis.

Clinical Trial Information

Protocol

TIRB# 31279

Phase

2

Condition(s)

Sarcoidosis

Investigator

Rohit Gupta, MD

Coordinator

Dave Miller, Sheril George

Visit clinicaltrials.gov for full description.

Contact

For more information about this trial or to inquire about eligibility, email [email protected] or call 215-707-1359.

Full Title

A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of a 12-week Administration of OATD-01, an Oral Inhibitor of Chitinase-1 (CHIT1), for the Treatment of Active Pulmonary Sarcoidosis (the KITE Study)

Related Clinical Trials

A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis

TIRB# 30808
  • Conditions: Sarcoidosis
  • Investigator: Rohit Gupta, MD
  • Coordinator: Sheril George, Dave Miller, Luis Cardenas-Osorio
View Details